T1	Participants 519 610	Forty-four patients with clinical or pathologic Stage I intermediate-grade or low-grade NHL
T2	Participants 957 986	RT plus CHOP group at 7 years
T3	Participants 1032 1047	RT-alone group.
T4	Participants 1082 1092	two groups
T5	Participants 1137 1173	patients with intermediate-grade NHL
T6	Participants 1357 1365	patients
T7	Participants 1556 1575	in 5 of 11 patients
